Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease
Pulmonary hypertension (PH) can develop from multiple etiologic mechanisms and disease states. Of all such conditions, left-sided heart disease (LHD) is commonly understood to be the most common etiology or mechanism. Given the widespread prevalence of left heart disease and the prognostic implicati...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Journal of Cardiovascular Development and Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2308-3425/12/7/238 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849303493946376192 |
|---|---|
| author | Elizabeth C. Ghandakly Akshat Banga Roop Kaw |
| author_facet | Elizabeth C. Ghandakly Akshat Banga Roop Kaw |
| author_sort | Elizabeth C. Ghandakly |
| collection | DOAJ |
| description | Pulmonary hypertension (PH) can develop from multiple etiologic mechanisms and disease states. Of all such conditions, left-sided heart disease (LHD) is commonly understood to be the most common etiology or mechanism. Given the widespread prevalence of left heart disease and the prognostic implications of PH, early diagnosis is imperative. More recently, the diagnostic cut-offs for mean pulmonary arterial pressure as well as peripheral vascular resistance have been lowered to achieve this objective. Despite these revised standards, the current indications for right heart catheterization are mostly aimed at identifying advanced disease. Proven vasodilator therapies for pulmonary arterial hypertension have so far not shown a meaningful role in the management of PH in LHD. This is largely related to the fact that multiple mechanisms and co-morbidities can independently lead to the development of PH in an individual patient. Understanding and identifying those phenotypes remain important in devising future treatment strategies. Molecular pathways that eventually lead to irreversibility of PH can provide another frontier in the pharmacologic management of PH in LHD. |
| format | Article |
| id | doaj-art-69cef289e5af4490b97396bea390fc1c |
| institution | Kabale University |
| issn | 2308-3425 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Cardiovascular Development and Disease |
| spelling | doaj-art-69cef289e5af4490b97396bea390fc1c2025-08-20T03:58:26ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252025-06-0112723810.3390/jcdd12070238Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart DiseaseElizabeth C. Ghandakly0Akshat Banga1Roop Kaw2Department of Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USADepartment of Internal Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA 02138, USADepartments of Hospital Medicine and Outcomes Research Anesthesiology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USAPulmonary hypertension (PH) can develop from multiple etiologic mechanisms and disease states. Of all such conditions, left-sided heart disease (LHD) is commonly understood to be the most common etiology or mechanism. Given the widespread prevalence of left heart disease and the prognostic implications of PH, early diagnosis is imperative. More recently, the diagnostic cut-offs for mean pulmonary arterial pressure as well as peripheral vascular resistance have been lowered to achieve this objective. Despite these revised standards, the current indications for right heart catheterization are mostly aimed at identifying advanced disease. Proven vasodilator therapies for pulmonary arterial hypertension have so far not shown a meaningful role in the management of PH in LHD. This is largely related to the fact that multiple mechanisms and co-morbidities can independently lead to the development of PH in an individual patient. Understanding and identifying those phenotypes remain important in devising future treatment strategies. Molecular pathways that eventually lead to irreversibility of PH can provide another frontier in the pharmacologic management of PH in LHD.https://www.mdpi.com/2308-3425/12/7/238pulmonary hypertensionleft heart disease |
| spellingShingle | Elizabeth C. Ghandakly Akshat Banga Roop Kaw Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease Journal of Cardiovascular Development and Disease pulmonary hypertension left heart disease |
| title | Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease |
| title_full | Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease |
| title_fullStr | Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease |
| title_full_unstemmed | Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease |
| title_short | Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease |
| title_sort | hemodynamic definitions phenotypes pathophysiology and evaluation of pulmonary hypertension related to left heart disease |
| topic | pulmonary hypertension left heart disease |
| url | https://www.mdpi.com/2308-3425/12/7/238 |
| work_keys_str_mv | AT elizabethcghandakly hemodynamicdefinitionsphenotypespathophysiologyandevaluationofpulmonaryhypertensionrelatedtoleftheartdisease AT akshatbanga hemodynamicdefinitionsphenotypespathophysiologyandevaluationofpulmonaryhypertensionrelatedtoleftheartdisease AT roopkaw hemodynamicdefinitionsphenotypespathophysiologyandevaluationofpulmonaryhypertensionrelatedtoleftheartdisease |